Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer

Clinical cancer research : an official journal of the American Association for Cancer Research, May 2025 | OF1-OF11

DOI: 10.1158/1078-0432.CCR-24-1304

Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer

Dev, Harveer ; Linch, Mark ; Narahari, Krishna ; Milne-Clark, Toby ; Cheung, Melissa ; Warren, Anne ; Malaviya, Alopa ; Gnanapragasam, Vincent ; Hernandez, Tatiana ; Bullock, Nicholas ; Machin, Andrea ; Dayimu, Alimu ; Robb, Tamsin ; Cromwell, Elizabeth ; Freeman, Alex ; Harrington, Elizabeth A ; Camacho, Niedzika ; Glont, Silvia ; Squatrito, Massimo ; Rotem, Asaf ; Moore, Luiza ; Hanson, Robert ; Dodd, Marc ; Anand, Shubha ; Kynaston, Howard ; Shaw, Greg ; Shah, Nimish ; Pacey, Simon

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer

PRODUCTS USED

Related Publications

Genomics Approaches for Increased Resolution in Forensic Investigations

Methods for Visualizing a Whole Human Chromosome in Super Resolution and Distinguishing Maternal and Paternal Homologs Genome-Wide

Without Safeguards, AI-Biology Integration Risks Creating Future Pandemics